4.7 Article

BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 216, Issue 6, Pages 1450-1464

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20182376

Keywords

-

Funding

  1. National Institutes of Health [R01 AI039614, R01 AI103760, R37 AI027998, T32 AI007313, F31 AI133716, T32 AI83196, R01 CA071540, R01 HD084459]
  2. University of Minnesota Microbiology and Immunology Department (Dennis W. Watson Fellowship)

Ask authors/readers for more resources

CD4(+) T helper 17 (Th17) cells protect vertebrate hosts from extracellular pathogens at mucosal surfaces. Th17 cells form from naive precursors when signals from the T cell antigen receptor (TCR) and certain cytokine receptors induce the expression of the ROR.t transcription factor, which activates a set of Th17-specific genes. Using T cell-specific loss-of-function experiments, we find that two components of the Polycomb repressive complex 1.1 (PRC1.1), BCL6 corepressor (BCOR) and KDM2B, which helps target the complex to unmethylated CpG DNA islands, are required for optimal Th17 cell formation in mice after Streptococcus pyogenes infection. Genome-wide expression and BCOR chromatin immunoprecipitation studies revealed that BCOR directly represses Lef1, Runx2, and Dusp4, whose products inhibit Th17 differentiation. Together, the results suggest that the PRC1.1 components BCOR and KDM2B work together to enhance Th17 cell formation by repressing Th17 fate suppressors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available